Medirom Healthcare Technologies (MRM) Short term Debt (2019 - 2024)
Medirom Healthcare Technologies has reported Short term Debt over the past 6 years, most recently at $4.1 million for Q4 2024.
- Quarterly results put Short term Debt at $4.1 million for Q4 2024, up 50.9% from a year ago — trailing twelve months through Dec 2024 was $4.1 million (up 50.9% YoY), and the annual figure for FY2024 was $4.1 million, up 50.9%.
- Short term Debt for Q4 2024 was $4.1 million at Medirom Healthcare Technologies, up from $2.7 million in the prior quarter.
- Over the last five years, Short term Debt for MRM hit a ceiling of $4.1 million in Q4 2024 and a floor of $701942.7 in Q4 2022.
- Median Short term Debt over the past 5 years was $2.3 million (2020), compared with a mean of $2.2 million.
- Biggest five-year swings in Short term Debt: tumbled 50.82% in 2022 and later surged 285.51% in 2023.
- Medirom Healthcare Technologies' Short term Debt stood at $2.3 million in 2020, then tumbled by 38.44% to $1.4 million in 2021, then tumbled by 50.82% to $701942.7 in 2022, then surged by 285.51% to $2.7 million in 2023, then skyrocketed by 50.9% to $4.1 million in 2024.
- The last three reported values for Short term Debt were $4.1 million (Q4 2024), $2.7 million (Q4 2023), and $701942.7 (Q4 2022) per Business Quant data.